ExodusPoint Capital Management LP Has $525,000 Stock Position in Paragon 28, Inc. (NYSE:FNA)

ExodusPoint Capital Management LP lessened its position in Paragon 28, Inc. (NYSE:FNAFree Report) by 14.4% in the fourth quarter, HoldingsChannel reports. The fund owned 50,835 shares of the company’s stock after selling 8,545 shares during the quarter. ExodusPoint Capital Management LP’s holdings in Paragon 28 were worth $525,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in Paragon 28 by 2,141.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after purchasing an additional 749,865 shares during the period. Vanguard Group Inc. grew its holdings in shares of Paragon 28 by 17.9% during the fourth quarter. Vanguard Group Inc. now owns 2,809,109 shares of the company’s stock valued at $29,018,000 after buying an additional 425,983 shares during the last quarter. Barclays PLC increased its position in shares of Paragon 28 by 180.6% during the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after acquiring an additional 54,591 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Paragon 28 in the 4th quarter worth about $547,000. Finally, Los Angeles Capital Management LLC bought a new position in Paragon 28 in the 4th quarter valued at about $505,000. Institutional investors own 63.57% of the company’s stock.

Paragon 28 Stock Performance

Shares of Paragon 28 stock opened at $13.02 on Friday. The business’s fifty day simple moving average is $13.03 and its 200 day simple moving average is $10.35. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. Paragon 28, Inc. has a 12 month low of $4.65 and a 12 month high of $13.13. The firm has a market capitalization of $1.09 billion, a P/E ratio of -17.59 and a beta of 1.47.

Paragon 28 (NYSE:FNAGet Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). The company had revenue of $71.75 million during the quarter, compared to analysts’ expectations of $70.81 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. As a group, analysts anticipate that Paragon 28, Inc. will post -0.64 EPS for the current year.

Insider Buying and Selling at Paragon 28

In related news, major shareholder Mvm Partners, Llc sold 1,044,295 shares of Paragon 28 stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $13.04, for a total value of $13,617,606.80. Following the sale, the insider now owns 7,810,588 shares of the company’s stock, valued at approximately $101,850,067.52. The trade was a 11.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 1,875,984 shares of company stock worth $24,359,971 over the last three months. 15.32% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages have recently commented on FNA. Stephens reissued an “equal weight” rating and issued a $13.00 price objective (down from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Canaccord Genuity Group set a $13.00 price target on Paragon 28 in a report on Wednesday, January 29th. William Blair cut Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating and set a $13.00 price objective on shares of Paragon 28 in a report on Wednesday, January 29th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Paragon 28 presently has an average rating of “Hold” and a consensus target price of $14.20.

Read Our Latest Stock Analysis on Paragon 28

Paragon 28 Profile

(Free Report)

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

See Also

Want to see what other hedge funds are holding FNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paragon 28, Inc. (NYSE:FNAFree Report).

Institutional Ownership by Quarter for Paragon 28 (NYSE:FNA)

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.